Viridian Therapeutics, Inc. (VRDN)

Viridian Therapeutics Statistics

Total Valuation

VRDN has a market cap or net worth of $1.34 billion. The enterprise value is $605.56 million.

Market Cap	1.34B
Enterprise Value	605.56M

Important Dates

The next estimated earnings date is Tuesday, February 25, 2025, after market close.

Earnings Date	Feb 25, 2025
Ex-Dividend Date	n/a

Share Statistics

VRDN has 79.21 million shares outstanding. The number of shares has increased by 42.07% in one year.

Current Share Class	79.21M
Shares Outstanding	79.21M
Shares Change (YoY)	+42.07%
Shares Change (QoQ)	+4.02%
Owned by Insiders (%)	0.08%
Owned by Institutions (%)	106.53%
Float	79.15M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	6,302.48
PB Ratio	2.57
P/TBV Ratio	2.58
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	2,005.17
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 18.55, with a Debt / Equity ratio of 0.03.

Current Ratio	18.55
Quick Ratio	18.21
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-103.04

Financial Efficiency

Return on equity (ROE) is -51.88% and return on invested capital (ROIC) is -34.14%.

Return on Equity (ROE)	-51.88%
Return on Assets (ROA)	-32.14%
Return on Capital (ROIC)	-34.14%
Revenue Per Employee	$3,213
Profits Per Employee	-$2.73M
Employee Count	94
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -23.85% in the last 52 weeks. The beta is 1.14, so VRDN's price volatility has been higher than the market average.

Beta (5Y)	1.14
52-Week Price Change	-23.85%
50-Day Moving Average	20.52
200-Day Moving Average	17.40
Relative Strength Index (RSI)	35.02
Average Volume (20 Days)	2,001,604

Short Selling Information

The latest short interest is 12.05 million, so 15.21% of the outstanding shares have been sold short.

Short Interest	12.05M
Short Previous Month	9.35M
Short % of Shares Out	15.21%
Short % of Float	15.23%
Short Ratio (days to cover)	7.01

Income Statement

In the last 12 months, VRDN had revenue of $302,000 and -$257.08 million in losses. Loss per share was -$4.26.

Revenue	302,000
Gross Profit	-159.46M
Operating Income	-283.04M
Pretax Income	-228.06M
Net Income	-257.08M
EBITDA	-282.47M
EBIT	-283.04M
Loss Per Share	-$4.26

Balance Sheet

The company has $753.24 million in cash and $23.27 million in debt, giving a net cash position of $729.97 million or $9.22 per share.

Cash & Cash Equivalents	753.24M
Total Debt	23.27M
Net Cash	729.97M
Net Cash Per Share	$9.22
Equity (Book Value)	707.50M
Book Value Per Share	6.55
Working Capital	725.99M

Cash Flow

In the last 12 months, operating cash flow was -$196.99 million and capital expenditures -$445,000, giving a free cash flow of -$197.43 million.

Operating Cash Flow	-196.99M
Capital Expenditures	-445,000
Free Cash Flow	-197.43M
FCF Per Share	-$2.49

Margins

Gross Margin	n/a
Operating Margin	-93,722.19%
Pretax Margin	-85,127.15%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

VRDN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-42.07%
Shareholder Yield	-42.07%
Earnings Yield	-19.25%
FCF Yield	-14.78%

Analyst Forecast

The average price target for VRDN is $36.44, which is 116.13% higher than the current price. The consensus rating is "Buy".

Price Target	$36.44
Price Target Difference	116.13%
Analyst Consensus	Buy
Analyst Count	12
Revenue Growth Forecast (5Y)	287.98%
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on November 13, 2020. It was a reverse split with a ratio of 0.0666666:1.

Last Split Date	Nov 13, 2020
Split Type	Reverse
Split Ratio	0.0666666:1

Scores

VRDN has an Altman Z-Score of 7.36 and a Piotroski F-Score of 2.

Altman Z-Score	7.36
Piotroski F-Score	2